We a good story
Quick delivery in the UK

Resistance to Targeted Therapies in Breast Cancer

About Resistance to Targeted Therapies in Breast Cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

Show more
  • Language:
  • English
  • ISBN:
  • 9783319888910
  • Binding:
  • Paperback
  • Pages:
  • 184
  • Published:
  • June 22, 2018
  • Edition:
  • 12017
  • Weight:
  • 314 g.
Delivery: 1-2 weeks
Expected delivery: December 13, 2024
Extended return policy to January 30, 2025

Description of Resistance to Targeted Therapies in Breast Cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast cancer (i.e., EGFR and Wnt signaling).

User ratings of Resistance to Targeted Therapies in Breast Cancer



Find similar books
The book Resistance to Targeted Therapies in Breast Cancer can be found in the following categories:

Join thousands of book lovers

Sign up to our newsletter and receive discounts and inspiration for your next reading experience.